Literature DB >> 23635625

Medical abortion follow-up with serum human chorionic gonadotropin compared with ultrasonography: a randomized controlled trial.

Ila Dayananda1, Rie Maurer, Jennifer Fortin, Alisa B Goldberg.   

Abstract

OBJECTIVE: To estimate whether follow-up with serum human chorionic gonadotropin (hCG) results in fewer unplanned visits and interventions than follow-up with ultrasonography.
METHODS: Women were randomized to either in-clinic serum hCG or ultrasound follow-up after medical abortion. The primary outcome, unplanned interventions and visits, was measured as a composite binary outcome including: additional clinic or emergency room visits, repeat dosing of misoprostol, and surgical evacuation of the uterus. Surveys were administered at initial follow-up and again 1 month after abortion to inquire about unscheduled visits, interventions, and patient satisfaction. Medical records were reviewed for evidence of additional interventions and visits.
RESULTS: A total of 376 patients was randomized. Most participants were white (56%), single (83%), nulliparous (63%), and had completed high school (96%). Average participant age was 26±6 years and average gestational age was 46±6 days. Within 2 weeks of abortion, there was no significant difference in the rate of unplanned interventions and visits between arms, 8.2% (13/159) in the serum hCG arm compared with 6.6% (10/151) in the ultrasound arm (relative risk 1.23, 95% confidence interval [CI] 0.56-2.73, P=.60). By 4 weeks postabortion, 4.4% (6/135) in the ultrasound arm and 1.4% (2/142) in the hCG arm had undergone surgical evacuation (relative risk 0.32, 95% CI 0.07-1.54, P=.16). The majority in both the serum hCG (88%) and ultrasound (95%) arms was satisfied with their assigned follow-up method.
CONCLUSION: Medical abortion follow-up with serum hCG does not reduce the rate of unplanned interventions and visits compared with ultrasonography. Overall, the number of unplanned interventions is low and both methods of follow-up are acceptable to women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635625     DOI: 10.1097/AOG.0b013e3182839fda

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.

Authors:  Andrea H Roe; Alice Abernathy; Anne N Flynn; Arden McAllister; Nathanael C Koelper; Mary D Sammel; Courtney A Schreiber; Sarita Sonalkar
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

2.  Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound.

Authors:  Bo Liang; Yang-Gui Xie; Xiao-Ping Xu; Chun-Hong Hu
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

3.  Closing the gap: actualising shared decision-making through effective medication abortion patient follow-up care.

Authors:  Erin Fagot
Journal:  BMJ Open Qual       Date:  2020-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.